SCHEMBL3955508

SCHEMBL3955508

Nc1ncc(-c2cccc3ncccc23)nc1NCCCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.49
GBA1 P04062 3/20 0.47
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
SYK P43405 3/20 0.44
JAK2 O60674 1/20 0.43
METAP1 P53582 1/20 0.43
PPP1CA P62136 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
APP P05067 3/20 0.43
PIK3CD O00329 1/20 0.43
PIK3R1 P27986 1/20 0.43
HPGD P15428 1/20 0.42
ACP1 P24666 2/20 0.42
EGFR P00533 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3955754 0.80 APP (0.54) GBA1SYKJAK2METAP1PPP1CA
SCHEMBL481889 0.76 ATR (0.53) ATRLDHALDHB
SCHEMBL481871 0.76 APP (0.52) ATRSYKAPPACP1EGFR
SCHEMBL3955491 0.75 APP (0.48) GBA1JAK2METAP1PPP1CAKMT2A
SCHEMBL481784 0.74 ATR (0.48) ATRHPGDEGFRLMNALDHA
SCHEMBL3955506 0.74 ATR (0.48) ATRKMT2ALDHALDHB
SCHEMBL3956534 0.74 ATR (0.48) ATRKMT2ALDHALDHB
SCHEMBL482010 0.74 ATR (0.48) ATRHPGDEGFRLMNALDHA
SCHEMBL481782 0.74 ATR (0.48) ATRHPGDEGFRLMNALDHA
SCHEMBL481930 0.74 ATR (0.59) ATRCYP1A2SYKKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078016-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051493-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed